DE69823240D1 - Immunmodulierende arzneimittelzusammenstellung - Google Patents

Immunmodulierende arzneimittelzusammenstellung

Info

Publication number
DE69823240D1
DE69823240D1 DE69823240T DE69823240T DE69823240D1 DE 69823240 D1 DE69823240 D1 DE 69823240D1 DE 69823240 T DE69823240 T DE 69823240T DE 69823240 T DE69823240 T DE 69823240T DE 69823240 D1 DE69823240 D1 DE 69823240D1
Authority
DE
Germany
Prior art keywords
immunodulating
pharmaceutical composition
medicinal composition
group
rheumatism
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69823240T
Other languages
English (en)
Other versions
DE69823240T2 (de
Inventor
Akira Matsumori
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toray Industries Inc
Original Assignee
Toray Industries Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries Inc filed Critical Toray Industries Inc
Application granted granted Critical
Publication of DE69823240D1 publication Critical patent/DE69823240D1/de
Publication of DE69823240T2 publication Critical patent/DE69823240T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
DE69823240T 1998-10-23 1998-10-23 Immunmodulierende arzneimittelzusammenstellung Expired - Fee Related DE69823240T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP1998/004804 WO2000024397A1 (fr) 1998-10-23 1998-10-23 Composition de medicament immunomodulateur

Publications (2)

Publication Number Publication Date
DE69823240D1 true DE69823240D1 (de) 2004-05-19
DE69823240T2 DE69823240T2 (de) 2005-04-28

Family

ID=14209266

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69823240T Expired - Fee Related DE69823240T2 (de) 1998-10-23 1998-10-23 Immunmodulierende arzneimittelzusammenstellung

Country Status (9)

Country Link
US (1) US6710046B1 (de)
EP (1) EP1123703B1 (de)
KR (1) KR100515918B1 (de)
CN (1) CN1148190C (de)
AT (1) ATE264104T1 (de)
CA (1) CA2347939C (de)
DE (1) DE69823240T2 (de)
ES (1) ES2215327T3 (de)
WO (1) WO2000024397A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8980894B2 (en) 2004-03-25 2015-03-17 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure
EP1579862A1 (de) 2004-03-25 2005-09-28 Boehringer Ingelheim Vetmedica Gmbh Verwendung von PDE III Ihibitoren zur Reduktion der Herzgrösse in an Herzversagen leidenden Säugern
EP1920785A1 (de) 2006-11-07 2008-05-14 Boehringer Ingelheim Vetmedica Gmbh Pimobendan-Cyclodextrin Komplex enthaltendes flüssiges Präparat
DE102007007751A1 (de) * 2007-02-16 2008-08-21 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue substituierte Arylsulfonylglycine, deren Herstellung und deren Verwendung als Arzneimittel
DE102007035333A1 (de) * 2007-07-27 2009-01-29 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue substituierte Arylsulfonylglycine, deren Herstellung und deren Verwendung als Arzneimittel
NL1037569C2 (en) * 2009-12-18 2011-06-21 Eurovet Animal Health B V Crystalline pimobendan, process for the preparation thereof, pharmaceutical composition and use.
WO2013135852A1 (en) 2012-03-15 2013-09-19 Boehringer Ingelheim Vetmedica Gmbh Pharmaceutical tablet formulation for the veterinary medical sector, method of production and use thereof
EA034430B1 (ru) 2013-07-19 2020-02-06 Бёрингер Ингельхайм Ветмедика Гмбх Жидкая водная фармацевтическая композиция с консервантами, содержащая этерифицированные производные циклодекстрина
ES2883448T3 (es) 2013-12-04 2021-12-07 Boehringer Ingelheim Vetmedica Gmbh Composiciones farmacéuticas mejoradas de pimobendán
US10537570B2 (en) 2016-04-06 2020-01-21 Boehringer Ingelheim Vetmedica Gmbh Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2516040C2 (de) * 1974-06-10 1984-12-20 Dr. Karl Thomae Gmbh, 7950 Biberach Benzimidazole, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
ES482789A0 (es) 1978-08-25 1980-12-01 Thomae Gmbh Dr K Procedimiento para la preparacion de nuevos bencimidazoles sustituidos en posicion 5 o 6 con un anillo de piridazinona
DE3932403A1 (de) * 1989-05-12 1991-04-11 Thomae Gmbh Dr K Neue arylsulfonamide, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
US5286736A (en) 1990-11-22 1994-02-15 Dr. Karl Thomae Gmbh Pyridyl compounds and pharmaceutical compositions containing these compounds
DE4237656A1 (de) * 1992-06-13 1993-12-16 Merck Patent Gmbh Benzimidazolderivate
US5981470A (en) * 1994-06-07 1999-11-09 The University Of Birmingham Uterine fibroid treatment
US5563143A (en) * 1994-09-21 1996-10-08 Pfizer Inc. Catechol diether compounds as inhibitors of TNF release
EP2223920A3 (de) * 1996-06-19 2011-09-28 Aventis Pharma Limited Substituierte Azabizyklische Verbindungen
FR2751649B1 (fr) * 1996-07-26 1998-08-28 Adir Nouveaux derives de benzimidazole, de benzoxazole et de benzothiazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
JP4426654B2 (ja) * 1997-09-18 2010-03-03 松森　　昭 免疫調節用医薬組成物

Also Published As

Publication number Publication date
CN1148190C (zh) 2004-05-05
CN1314815A (zh) 2001-09-26
KR20010107927A (ko) 2001-12-07
ATE264104T1 (de) 2004-04-15
EP1123703A4 (de) 2002-11-20
DE69823240T2 (de) 2005-04-28
KR100515918B1 (ko) 2005-09-20
CA2347939C (en) 2006-10-10
ES2215327T3 (es) 2004-10-01
WO2000024397A1 (fr) 2000-05-04
US6710046B1 (en) 2004-03-23
EP1123703A1 (de) 2001-08-16
CA2347939A1 (en) 2000-05-04
EP1123703B1 (de) 2004-04-14

Similar Documents

Publication Publication Date Title
ES2182852T3 (es) Derivados de prolinamida.
DK0582368T3 (da) Thienobenzodiazepinderivater til behandling af forstyrrelser i centralnervesystemet
HU9600834D0 (en) Quinazoline derivatives
PT1029853E (pt) Derivados biciclicos heteroaromaticos uteis como agentes anticancerigenos
NO306464B1 (no) Benzimidazolforbindelser, farmasöytiske preparater som omfatter slike forbindelser, samt anvendelse av forbindelsene for fremstilling av medikamenter
HU9603433D0 (en) Novel 4-6-diaryl-pyrimidine-derivatives and salts thereof
EP0903347A4 (de)
DE69823240D1 (de) Immunmodulierende arzneimittelzusammenstellung
PT870757E (pt) Derivados de adamantano substituidos por fluoro
DK0659427T3 (da) 2-Phenyl-3-azoylbenzothiophener til forøgelse af thrombomodulinekspression
MD1560F2 (en) Cyclic compounds, pharmaceutical compositions on base thereof and methods of treatment of infections or diseases provoked by retroviruses.
PT98773A (pt) Processo para a preparacao de di-hidropirido/4,3-d/pirimidinas substituidas na posicao 4 e de composicoes farmaceuticas analgesicas e antiinflamatorias que as contem
DE69828197D1 (de) Amidderivate zur behandlung neurodegenerativer erkrankungen der netzhaut
DK0617959T3 (da) Lægemiddel til behandling af hudsygdomme
SE9702716D0 (sv) Substituted phenylazacycloalkanes in the treatment of cognitive disorders
DE69527854T2 (de) Derivate substituierter amidinonaphthylester
DK0784973T3 (da) Quinoxalinderivater til behandling af tinnitus
PT889044E (pt) Derivados do 5-(heteroaril)alquil-3-oxo-pirido-(1,2-a)benzimidazole-4-carboxamida (pbi) uteis no tratamento de perturbacoes do sistema nervoso central
TW275629B (de)
ES2116528T3 (es) Nuevo compuesto, la leustroducsina h, su preparacion y su utilizacion terapeutica.
DK653687D0 (da) Middel til behandling af nyresygdomme

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee